NCT02537561View on ClinicalTrials.gov

Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Solid TumorsCarcinoma, Non-Small Cell LungNon-Small Cell Lung CancerNon-Small-Cell Lung CarcinomaNonsmall Cell Lung Cancer
Interventions
DRUG

Cisplatin

DRUG

Gemcitabine

DRUG

Talazoparib

Sponsors

Collaborators (1)

BioMarin Pharmaceutical
All Listed Sponsors
collaborator

BioMarin Pharmaceutical

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT02537561 - Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter